Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAT2206 vs Stelara in moderate to severe plaque psoriasis
NCT04728360Phase 3Completed
- Sponsor
- Bio-Thera Solutions, Ltd.
- Start
- Jul 2021
- Primary completion
- Oct 2022
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of Starjemza in plaque psoriasis, sponsored by Bio-Thera Solutions, Ltd.. Started Jul 2021; status: completed.
02
Drugs
Starjemza
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT04728360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04728360.